Class Action Claims Unisom Simple Slumbers Falsely Marketed as ‘Natural’
January 11, 2023 A class action alleges that Unisom Simple Slumbers are misleadingly marketed as “natural” because the products contain several artificial ingredients.
Lawsuit Filings
Class Action Claims Sanofi Knew ‘For Years’ of Zantac NDMA Contamination
December 4, 2019 A class action claims Zantac manufacturer Sanofi knew the heartburn drug contained NDMA yet concealed this information from the public.
Class Action Claims Sanofi Knowingly Sold Zantac Contaminated with Probable Carcinogen
November 14, 2019 A proposed class action claims Sanofi knowingly manufactured and sold Zantac contaminated with the probable carcinogen N-Nitrosodimethylamine (NDMA).
Sanofi, Boehringer Ingelheim Hit with Class Action Over Allegedly Unsafe Levels of Probable Carcinogen in Zantac [DISMISSED]
September 17, 2019 Zantac makers Sanofi-Aventis U.S. and Boehringer Ingelheim face a class action over the allegedly high NDMA content in the over-the-counter heartburn and indigestion drug.